Chemical Name:6-(Benzylamino)-2-(2-hydroxyethylamino)-9-methylpurine
Biological Activity:
Cyclin-dependent kinase inhibitor that competes for the ATP
binding site of the kinase. Selectively inhibits cdc2/cyclin B (IC50
= 7 μM), cdk2/cyclin A (IC50
= 7 μM), cdk2/cyclin E (IC50
= 7 μM), cdk/p35 kinase (IC50
= 3 μM)and ERK1/MAP kinase (IC50 = 25 μM). Arrests human fibroblasts in the G1 phase.
Veselyet al (1994) Inhibition of cyclin-dependent kinases by
purine analogues. Eur.J.Biochem. 224 771. Abrahamet al
(1995) Cellular effects of olomoucine, an inhibitor of cyclin-dependent
kinases. Biol.Cell 83 105. Alessiet al (1998) The
cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human
fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
Exp.Cell.Res. 245 8.